Page last updated: 2024-11-13

c.i. 42640

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Acid Violet 6B: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID23691992
MeSH IDM0048925

Synonyms (66)

Synonym
550x5x78wk ,
violet kysela 49
violet potravinarska 2
unii-550x5x78wk
benzenemethanaminium, n-(4-((4-(dimethylamino)phenyl)(4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)methylene)-2,5-cyclohexadien-1-ylidene)-n-ethyl-3-sulfo-, inner salt, sodium salt (1:1)
fd & c violet no. 1
acid violet 6b
acid violet
c.i. acid violet 49 (sodium salt)
dispersed violet 12197
acid fast violet 5bn
ci 42640
cogilor violet 411.12
pergacid violet 2b
benzyl violet 3b
calcocid violet 4bns
c.i. 42640
fd&c violet no. 1
acid violet s
c.i. food violet 2
ci acid violet 49, sodium salt
intracid violet 4bns
eriosin violet 3b
violet 5b
c.i. acid violet 49
polaxal violet 6b
acid violet 4bns
ci food violet 2
violet 2
fast acid violet 5bn
einecs 216-901-9
food violet 2
aizen acid violet 5bh
ci acid violet 49
acilan violet s4bn
fd and c violet no. 1
ccris 80
fd and c violet 1
violet potravinarska 2 [czech]
pergacid violet 3b
kiton violet 4bns
ammonium, (4-(p-(dimethylamino)-alpha-(p-(ethyl(m-sulfobenzyl)amino)phenyl)benzylidene)-2,5-cyclohexadien-1-ylidene)ethyl(m-sulfobenzyl)-, hydroxide, inner salt, sodium salt
benzenemethanaminium, n-(4-((4-(dimethylamino)phenyl)(4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)methylene)-2,5-cyclohexadien-1-ylidene)-n-ethyl-3-sulfo-, hydroxide, inner salt, sodium salt
(4-((4-(dimethylamino)phenyl)(4-(ethyl(3-sulphonatobenzyl)amino)phenyl)methylene)cyclohexa-2,5-dien-1-ylidene)(ethyl)(3-sulphonatobenzyl)ammonium, sodium salt
af violet no. 1
coomassie violet
formyl violet s4bn
a.f. violet no. 1
aizen food violet no. 1
(4-(p-(dimethylamino)-alpha-(p-(ethyl(m-sulfobenzyl)amino)phenyl)benzylidene)-2,5-cyclohexadien-1-ylidene)ethyl(m-sulfobenzyl)ammonium hydroxide inner salt
tertracid brilliant violet 6b
11386 violet
acid violet 5bn
violet no. 1
d and c violet no. 1
violet 6b
hsdb 2934
benzenemethanaminium, n-(4-((4-(dimethylamino)phenyl)(4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)methylene)-2,5-cyclohexadien-1-ylidene)-n-ethyl-3-sulfo-, inner salt, sodium salt
violet kysela 49 [czech]
benzyl violet 4b
[4-[bis[4-[ethyl-[(3-sulfophenyl)methyl]amino]phenyl]methylidene]cyclohexa-2,5-dien-1-ylidene]-dimethylazanium
benzyl violet [ii]
acid violet 6b [hsdb]
(4-((4-(dimethylamino)phenyl)(4-(ethyl(3-sulphonatobenzyl)amino)phenyl)methylene)cyclohexa-2,5-dien- 1-ylidene)(ethyl)(3-sulphonatobenzyl)ammonium, sodium salt
fd&c violet no. 1 (delisted)
sodium;3-[[4-[(4-dimethylazaniumylidenecyclohexa-2,5-dien-1-ylidene)-[4-[ethyl-[(3-sulfophenyl)methyl]amino]phenyl]methyl]-n-ethylanilino]methyl]benzenesulfonate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.79 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]